Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Letter to the Editor

Accountability in AI medicine: A critical appraisal of ChatGPT in patient self-management and screening

Jiawen Wang, Tian Xia

Clin Mol Hepatol. 2025;31(1):e1-e2. Published online September 26, 2024

DOI: https://doi.org/10.3350/cmh.2024.0769

View: 435 Download: 37

Original Article

Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma

Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo

Clin Mol Hepatol. 2023;29(3):721-732. Published online March 22, 2023

DOI: https://doi.org/10.3350/cmh.2023.0089

View: 22581 Download: 1,612 Web of Science: 261 Crossref: 272

Guideline

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea

Clin Mol Hepatol. 2022;28(4):583-705. Published online October 1, 2022

DOI: https://doi.org/10.3350/cmh.2022.0294

View: 16855 Download: 801 Web of Science: 147 Crossref: 163

KASL clinical practice guidelines for management of chronic hepatitis B

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2022;28(2):276-331. Published online April 1, 2022

DOI: https://doi.org/10.3350/cmh.2022.0084 Correction in: Clin Mol Hepatol 2022;28(4):940

View: 12457 Download: 624 Web of Science: 53 Crossref: 66

Review

The management of post-transplantation recurrence of hepatocellular carcinoma

Luckshi Rajendran, Tommy Ivanics, Marco PAW Claasen, Hala Muaddi, Gonzalo Sapisochin

Clin Mol Hepatol. 2022;28(1):1-16. Published online October 5, 2021

DOI: https://doi.org/10.3350/cmh.2021.0217

View: 9775 Download: 356 Web of Science: 41 Crossref: 45

KASL clinical practice guidelines: management of hepatitis C

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2016;22(1):76-139. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.76

View: 27411 Download: 209 Web of Science: 65 Crossref: 55

New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis

Hyun Young Woo, Jeong Heo

Clin Mol Hepatol. 2015;21(2):115-121. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.115

View: 10930 Download: 154 Web of Science: 41 Crossref: 31

Personalized treatment of hepatitis B

Anna S. Lok

Clin Mol Hepatol. 2015;21(1):1-6. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.1

View: 9223 Download: 142 Web of Science: 19 Crossref: 19

Management of viral hepatitis in liver transplant recipients

Soung Won Jeong, YoungRok Choi, Jin-Wook Kim

Clin Mol Hepatol. 2014;20(4):338-344. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.338

View: 9178 Download: 80 Web of Science: 3 Crossref: 3

KASL Clinical Practice Guidelines: Management of chronic hepatitis B

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2012;18(2):109-162. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.109

View: 16154 Download: 109 Crossref: 121

Current status of Liver diseases in Korea: Liver cirrhosis

Jeong Won Jang

Clin Mol Hepatol. 2009;15(60):40-49. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.S6.S40

View: 7209 Download: 128 Crossref: 24

11

Special Contribution : Practice guidelines for management of hepatocellular carcinoma 2009

Korean Liver Cancer Study Group and National Cancer Center, Korea

Clin Mol Hepatol. 2009;15(3):391-423. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.391

View: 9786 Download: 110 Crossref: 208

2

Wilson Disease: an Update

Jeong Kee Seo

Clin Mol Hepatol. 2006;12(3):333-363. Published online January 1, 2000

View: 7003 Download: 241

Special Surgical Management of Hepatocellular Carcinoma

Kuhn Uk Lee,Hyuk Joon Lee

Clin Mol Hepatol. 2002;8(1):1-21. Published online January 1, 1970

View: 2751 Download: 13

1 |

Viewed By 6146	MAFLD: How is it different from NAFLD?
Viewed By 5249	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4973	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4166	Examining the therapeutic landscape of beta-blockers in portal hypertension
Viewed By 3941	Gut microbiome and metabolome signatures in liver cirrhosis-related complications

Cited By 272	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 225	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 154	MAFLD: How is it different from NAFLD?
Cited By 79	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 76	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search